These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 18597823)
21. One-third of the Swedish male population over 50 years of age suffers from lower urinary tract symptoms. Stranne J; Damber JE; Fall M; Hammarsten J; Knutson T; Peeker R Scand J Urol Nephrol; 2009; 43(3):199-205. PubMed ID: 19347773 [TBL] [Abstract][Full Text] [Related]
22. Urodynamic evaluation of patients with lower urinary tract symptoms and small prostate volume. Gomes CM; Nunes RV; Araújo RM; Sacomani CR; Trigo-Rocha FE; Bruschini H; Srougi M Urol Int; 2008; 81(2):129-34. PubMed ID: 18758208 [TBL] [Abstract][Full Text] [Related]
23. Concurrent improvement of the metabolic syndrome and lower urinary tract symptoms upon normalisation of plasma testosterone levels in hypogonadal elderly men. Haider A; Gooren LJ; Padungtod P; Saad F Andrologia; 2009 Feb; 41(1):7-13. PubMed ID: 19143723 [TBL] [Abstract][Full Text] [Related]
24. Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study. Yokoyama T; Uematsu K; Watanabe T; Sasaki K; Kumon H; Nagai A; Scand J Urol Nephrol; 2009; 43(4):307-14. PubMed ID: 19396723 [TBL] [Abstract][Full Text] [Related]
25. Voiding patterns in men and women with lower urinary tract symptoms combined with nocturia. Paick JS; Kim SW; Oh SJ; Ku JH Int J Urol; 2007 Aug; 14(8):699-703. PubMed ID: 17681058 [TBL] [Abstract][Full Text] [Related]
26. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study. Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631 [TBL] [Abstract][Full Text] [Related]
27. Effects of tamsulosin on lower urinary tract symptoms due to double-J stent: a prospective study. Wang CJ; Huang SW; Chang CH Urol Int; 2009; 83(1):66-9. PubMed ID: 19641362 [TBL] [Abstract][Full Text] [Related]
28. Differences between bothersome and non-bothersome night-time frequency. Yoshimura K; Kamoto T; Oka Y; Tsukamoto T; Oshiro K; Suzukamo Y; Kinukawa N; Ogawa O Neurourol Urodyn; 2007; 26(7):1014-9. PubMed ID: 17600370 [TBL] [Abstract][Full Text] [Related]
29. Correlation of prostate volume with international prostate symptom score and quality of life in men with benign prostatic hyperplasia. Agrawal CS; Chalise PR; Bhandari BB Nepal Med Coll J; 2008 Jun; 10(2):104-7. PubMed ID: 18828432 [TBL] [Abstract][Full Text] [Related]
30. Asthma-like symptoms are increased in the metabolic syndrome. Lee EJ; In KH; Ha ES; Lee KJ; Hur GY; Kang EH; Jung KH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; Yoo SH J Asthma; 2009 May; 46(4):339-42. PubMed ID: 19484665 [TBL] [Abstract][Full Text] [Related]
31. Differential impact of lower urinary tract symptoms on generic and disease-specific quality of life in men and women. Araki I; Tsuchida T; Nomura T; Fukasawa M; Takihana Y; Koyama N; Takeda M Urol Int; 2008; 81(1):60-5. PubMed ID: 18645273 [TBL] [Abstract][Full Text] [Related]
32. Overlap of voiding symptoms, storage symptoms and pain in men and women. Clemens JQ; Markossian TW; Meenan RT; O'Keeffe Rosetti MC; Calhoun EA J Urol; 2007 Oct; 178(4 Pt 1):1354-8; discussion 1358. PubMed ID: 17706719 [TBL] [Abstract][Full Text] [Related]
33. Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB. Roehrborn CG; Kaplan SA; Kraus SR; Wang JT; Bavendam T; Guan Z Urology; 2008 Nov; 72(5):1061-7; discussion 1067. PubMed ID: 18817961 [TBL] [Abstract][Full Text] [Related]
34. Psychometric analysis of international prostate symptom score for female lower urinary tract symptoms. Okamura K; Nojiri Y; Osuga Y; Tange C Urology; 2009 Jun; 73(6):1199-202. PubMed ID: 19371926 [TBL] [Abstract][Full Text] [Related]
35. Cauda equina symptoms are closely related to male lower urinary tract symptoms. Imai A; Yamamoto H; Hatakeyama S; Iwabuchi I; Yoneyama T; Hashimoto Y; Koie T; Kamimura N; Danjo K; Ono A; Ohyama C Urol Int; 2010; 84(3):325-9. PubMed ID: 20389164 [TBL] [Abstract][Full Text] [Related]
36. Influence of coping styles on quality of life in men with new and increasing lower urinary tract symptoms. The Krimpen Study in community-dwelling men. Kok ET; Groeneveld FP; Busschbach JJ; Hop WC; Bosch JL; Thomas S; Bohnen AM Urol Int; 2007; 79(3):226-30. PubMed ID: 17940354 [TBL] [Abstract][Full Text] [Related]
37. The association between vascular risk factors and lower urinary tract symptoms in both sexes. Ponholzer A; Temml C; Wehrberger C; Marszalek M; Madersbacher S Eur Urol; 2006 Sep; 50(3):581-6. PubMed ID: 16519993 [TBL] [Abstract][Full Text] [Related]
38. Lower urinary tract symptoms and their impact on quality of life after successful renal transplantation. Mitsui T; Shimoda N; Morita K; Tanaka H; Moriya K; Nonomura K Int J Urol; 2009 Apr; 16(4):388-92. PubMed ID: 19207112 [TBL] [Abstract][Full Text] [Related]
39. Determinants of seeking of primary care for lower urinary tract symptoms: the Krimpen study in community-dwelling men. Kok ET; Groeneveld FP; Gouweloos J; Jonkheijm R; Bosch JL; Thomas S; Bohnen AM Eur Urol; 2006 Oct; 50(4):811-7. PubMed ID: 16632189 [TBL] [Abstract][Full Text] [Related]
40. The impact of self-management of lower urinary tract symptoms on frequency-volume chart measures. Yap TL; Brown C; Cromwell DA; van der Meulen J; Emberton M BJU Int; 2009 Oct; 104(8):1104-8. PubMed ID: 19485993 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]